SeqLL
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3 Federal St, Billerica, Massachusetts, ...Phone Number
(781) 460-6016Website
www.seqll.comRevenue
<$5 MillionStock Symbol
SQLIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SeqLL
SeqLL Inc. ("SeqLL") is a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple "omics" fields. The Company intends to leverage their expertise with True Single Molecule Sequencing ("tSMS®") technology to enable researchers and clinicians to contribute major advancements to scientific research and development by accelerating one's understanding of the molecular mechanisms of disease and fundamental biological processes.Explore more
SeqLL Org Chart
EA
Senior Scientist
JZ
Bioinformatics Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SeqLL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if SeqLL had a recent Job posting/layoffs
Earning: See what the market has to say on SeqLL recently announced quarterly report
Product Launch: Get notified when SeqLL launches new products
Funding: Get notified immidiatlly once SeqLL has new funding data
Check out if SeqLL is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at SeqLL
Check if SeqLL has recently received funding, and reach out quickly before it becomes old news!
SeqLL, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to SeqLL
Compare insights from companies similar to SeqLL, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SeqLL is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SeqLL is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SeqLL.
SeqLL financials insights
Gather financial insights about SeqLL, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$1M
2020
Debt
$150K
SeqLL Tech Stack
A closer look at the technologies used by SeqLL
See more technologies
Most Recent Scoops
Earnings
Pain Point, Financial Planning, Business Development
Earnings
Asset Management, Sales, Sales Development
Earnings
Mergers & Acquisitions, Sales
Earnings
Asset Management, Digital Technology, Intellectual Property
Earnings
Mergers & Acquisitions, Business Development
SeqLL News & Media
SeqLL Inc. Enters into a Definitive Merger Agreement with Lyneer Staffing Solutions and Atlantic Acquisition Corp.
BILLERICA, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), a technology company providing life sciences instrumentation and research services, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with Lyneer Investments, LLC (“Lyneer”), the indirect parent company of Lyneer Staffing Solutions, LLC and Atlantic Acquisition Corp. (“Atlantic”), and related parties, pursuant to which Lyneer will become a wSeqLL Provides First Quarter 2023 Financial Results
BILLERICA, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services aimed at the development of novel scientific assets and intellectual property, today announced its operating and financial results for the first quarter ended March 31, 2023.SeqLL Inc. Announces Pricing of $1.8 Million Registered Direct Offering
BILLERICA, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (NASDAQ: SQL and SQLLW) (“SeqLL” or the “Company”), a technology company providing life sciences instrumentation and research services, today announced that it has entered into a securities purchase agreement (the “Agreement”) with institutional investors to purchase 2,000,000 of its shares of common stock at a purchase price of $0.90 per share of common stock in a registered direct offering (the “Offering”). The gross proceeds toSeqLL Announces CRADA with the FBI
BILLERICA, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL”, NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced the establishment of a two-year Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Justice’s Federal Bureau of Investigation (FBI). Under this CRADA, SeqLL and the FBI Laboratory Division (FBI LD) will seek to evaluate and determine the forensic capabilities of direct RNA sequenci
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding SeqLL
Sign Up For FreeTo access detailed company insights
SeqLL Inc. ("SeqLL") is a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple "omics" fields. The Company intends to leverage their expertise with True Single Molecule Sequencing ("tSMS®") technology to enable researchers and cl... Read More
